Get flash to fully experience Pearltrees
Email is taking up too much time in our lives. Do yourself and your recipients a favor by making your emails 3 sentences or less. If we all do it, imagine the time we’ll have to do other things. If this was an actual email reply and not a blog post, it would have ended before this sentence started.
My name is Carol Sormilic and I’m a vice president at IBM where I am responsible for the technology that drives our workplace. I’m moving my work and my life from the United States to the “other side of the world” where I’ll be located in Shanghai, China. In this space I plan to chronicle my adventure. Disclaimer : The content here is my own and does not necessarily represent my employer’s positions, strategies or opinions.
For those of you interested in life science VCs, M&A and IPO’s, the latest OnBioVC report is now available for download here (pdf). Inevitably, in the current economic climate, the financial trend is a downwards one, as evidenced by the findings: “The 3Q10 OnBioVC Trend Analysis tracked, in aggregate, 70 biopharma, diagnostic, device, medical-IT and biofuel venture financings totaling $1,420.0M.
This week heralds a busy one with the upcoming annual NY Chemotherapy Foundation (Greenspan) meeting that begins tomorrow at the Marriott Marquis in Times Square with the Pediatric session in the afternoon and finishes on Saturday with the Nursing session. I’ll be at the Greenspan event from Weds to Fri, please do say hello if you see me around. In the meantime, I’ve been pleasantly surprised at the number of signups to the conference newsletter (see the sign up widget in the right hand margin —>). The first one, from AACR on colon cancer, goes out this on Wednesday week, please sign up before then if you would like to receive it. More newsletters will follow soon on the Greenspan Meeting, ASH and SABCS. I’ve just added a new meeting to my January conference schedule and will be attending the 6th International Society of Gastroenterological Carcinogenesis in Houston, Texas.
RT @ericgarland: Scott Adams' fantastic suggestion to end political parties in America http://bit.ly/bCbrFFImagine a democratic political system in which no one is allowed to be a member of a political party. How would things be different? My hypothesis is that confirmation bias, or cognitive dissonance, or something of that nature, influences voters to irrationally agree with the platform of their own party no matter what the facts suggest.
From PharmaGossip, we have a full accounting of the recent settlements between the US Department of Justice and Big Pharma companies -- for some sort of fraudulent or otherwise criminal activity. PharmaGossip: Big Pharma settlements with the DOJ - let's look at the scorecard . The score stands with the DOJ collecting $5.3 B in fines for bad behavior.
Our approach is based on the ideas that tumorigenesis is a continuous process and that the gene-expression signature underlying the development of bone metastases starts to form in the early stages of prostate tumorigenesis and becomes well developed in the later stages. We have assumed that combining meta-analyses of different steps of prostate carcinogenesis and assigning greater weight to more-specific data might improve identification of genes associated with prostate tumorigenesis, especially those involved in the development of bone metastases; therefore, we have up-weighted the third level of meta-analysis. First level of the meta-analysis The tendency of prostate tumor to metastasize to bone is a hallmark of prostate tumorigenesis. Breast and lung cancer also often metastasize to bone, although not as frequently as prostate cancer does. Bone-metastasizing cancers may share a gene-expression signature that predisposes them to form bone metastases.
Last night, TechCrunch reported that Google will now require sites that import e-mail addresses from Gmail to also allow export of their data. The move was clearly aimed at Facebook, which has kept Google from accessing their users’ data. In response, many people have mentioned that while Facebook lets users download some data, they’re still not able to download an e-mail address book of their Facebook contacts. However, that’s not quite the case. Back in March, I published a guide to exporting data from Facebook using various tricks and FQL queries.
1) Burkitt's lymphoma, Lymphoblastic lymphoma, Chronic lymphocytic leukemia (Small lymphocytic lymphoma may be included) 2) Chemotherapy or radiation therapy or other investigational agents within 4 weeks prior to entering the study 3) Previous radioimmunotherapy within 12 weeks 4) Prior therapy with HDAC or mTOR inhibitors i.e. temsirolimus, vorinostat (the list is not inclusive of investigational agents in these classes of drugs)
Andrew Banchich spotted a new Gmail feature that lets you record calls. I don't see the call record button in my account, so it's probably an experimental feature that's not yet widely available. It's similar to the call recording feature from Google Voice . "In order to record your call, simply press 4. You can do it when you first accept a call, or any time after it's started.
Companies that copy biotechnology drugs, led by Teva Pharmaceutical Industries Ltd. , will be able to bypass a new process set up by the U.S. health overhaul to get their products approved, regulators said. The Food and Drug Administration will allow generic-drug makers to use either the new system, which requires them to give proprietary data to brand-name drugmakers at the point they seek approval, or an older system used to clear novel biologics, which keeps that information private, said spokeswoman Sandy Walsh . While the FDA wasn’t expected to take an immediate stand on the process, Walsh said the new law accommodates both.
Management speak - don't you just hate it? Emphatically yes, judging by readers' responses to writer Lucy Kellaway's campaign against office jargon . Here, we list 50 of the best worst examples. 1. "When I worked for Verizon, I found the phrase going forward to be more sinister than annoying.
Sometimes zapping a tumor with ionizing radiation doesn’t work out as planned. The tumor shrinks at first, but stem cells within the tumor survive and eventually seed the growth of new, more aggressive tumors. Now researchers have shown that this extraordinary radiation-resistance among tumor stem cells can be dramatically lowered by heating them up. The results were obtained in highly aggressive mouse and human breast cancer tumors, but the technique could possibly be used against many types of cancer.